We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.91B
AUM Growth
+$545M
Cap. Flow
+$210M
Cap. Flow %
5.36%
Top 10 Hldgs %
40.38%
Holding
2,228
New
603
Increased
482
Reduced
356
Closed
557

Sector Composition

Rank Sector Weight
1 Financials 9.4%
2 Technology 6.32%
3 Consumer Discretionary 5.14%
4 Industrials 4.27%
5 Communication Services 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HEXO
1476
CALL
DELISTED
HEXO Corp. Common Shares
HEXO
$97K ﹤0.01%
3,750
+614
+20% +$28.5K
CRZN
1477
DELISTED
Corazon Capital V838 Monoceros Corp Class A Ordinary Shares
CRZN
$97K ﹤0.01%
10,000
EBAC
1478
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
$97K ﹤0.01%
10,000
UWMC icon
1479
UWM Holdings
UWMC
$478M
$95K ﹤0.01%
+13,602
New +$101K
GFI icon
1480
Gold Fields
GFI
$36.8B
$93K ﹤0.01%
+11,411
New +$102K
TMC icon
1481
CALL
TMC The Metals Company
TMC
$1.92B
$92K ﹤0.01%
+20,200
New +$193K
TARA icon
1482
Protara Therapeutics
TARA
$231M
$91K ﹤0.01%
13,155
+1,455
+12% +$11.3K
ML
1483
CALL
DELISTED
MoneyLion Inc.
ML
$91K ﹤0.01%
450
-57
-11% -$16.7K
LITS
1484
Lite Strategy Inc
LITS
$29.6M
$87K ﹤0.01%
1,575
+425
+37% +$23.4K
GGGVR
1485
DELISTED
G3 VRM Acquisition Corp. Rights
GGGVR
$87K ﹤0.01%
+275,000
New +$95.9K
MEUSW
1486
DELISTED
23andMe Holding Co Warrant
MEUSW
$84K ﹤0.01%
45,471
GHG
1487
GreenTree Hospitality
GHG
$113M
$82K ﹤0.01%
10,000
-41,000
-80% -$377K
BRIVW
1488
DELISTED
B. Riley Principal 250 Merger Corp. Warrant
BRIVW
$82K ﹤0.01%
+116,666
New +$109K
TLIS
1489
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$77K ﹤0.01%
+822
New +$110K
FFAIW
1490
DELISTED
Faraday Future Intelligent Electric Warrant
FFAIW
$76K ﹤0.01%
44,735
MMAT
1491
CALL
DELISTED
Meta Materials Inc. Common Stock
MMAT
$76K ﹤0.01%
+131
New +$57.1K
AUY
1492
DELISTED
Yamana Gold, Inc.
AUY
$75K ﹤0.01%
+19,000
New +$80.5K
SIOX
1493
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$74K ﹤0.01%
34,000
GOCO
1494
DELISTED
GoHealth
GOCO
$72K ﹤0.01%
+954
New +$101K
TOON icon
1495
CALL
Kartoon Studios
TOON
$35.3M
$71K ﹤0.01%
5,220
-1,730
-25% -$26.9K
EDU icon
1496
New Oriental
EDU
$9.24B
$69K ﹤0.01%
3,374
-13,092
-80% -$416K
TAL icon
1497
TAL Education Group
TAL
$6.93B
$69K ﹤0.01%
+14,288
New +$127K
TELL
1498
CALL
DELISTED
Tellurian Inc.
TELL
$69K ﹤0.01%
17,600
-1,500
-8% -$5.13K
WVE icon
1499
Wave Life Sciences
WVE
$1.2B
$68K ﹤0.01%
+13,893
New +$84.2K
KPLTW
1500
DELISTED
Katapult Holdings Warrant
KPLTW
$67K ﹤0.01%
+44,081
New +$83.3K

Similar funds

Prelude Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Prelude Capital Management held 2,228 positions worth $3.91B, up 16% from $3.36B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Prelude Capital Management deployed $210M of net new capital in Q3 2021, opening 603 new positions and adding to 482 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.

By sector, the portfolio is most concentrated in Financials at 9.4% of assets, up from 8.9% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Frontier Communications, an estimated $8.65M trimmed.

  • Prelude Capital Management's largest Q3 2021 buy was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.
  • Prelude Capital Management added most to Valaris in Q3 2021, an estimated $24.1M increase.
  • Prelude Capital Management's biggest Q3 2021 reduction was Frontier Communications, cutting an estimated $8.65M.
  • Prelude Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $22.9M.
  • Prelude Capital Management's ten largest holdings make up 40% of its $3.91B portfolio in Q3 2021.
  • Prelude Capital Management opened 603 new positions and closed 557 in Q3 2021.
  • Prelude Capital Management's portfolio value rose 16% quarter-over-quarter to $3.91B.

Based on Prelude Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.